Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly To Suppress Cancer Metastasis

In validation studies, genetic disruption of CaMKK2 expression or inhibition of its activity with small molecule inhibitors disrupted spontaneous metastatic outgrowth from primary tumors in murine xenograft models of TNBC.